Key Clinical Message:
18F-FDG PET/CT has clinical relevance in HCL at diagnosis and for the follow-up of patients treated, especially in case of atypical presentations such as bone involvements (which are probably underestimated) and poor bone marrow infiltration.
Keywords : Hairy cell leukemia, HCL, Bone lesions, 18F-FDG PET/CT, PNA, Cladribine, Rituximab